TrialOncoTargets and therapy2020

Impact of Programmed Death Ligand 1 Expression in Advanced Non-Small-Cell Lung Cancer Patients, Treated by Chemotherapy (GFPC 06-2015 Study).

Jean-Bernard Auliac et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.